# Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children

> **NCT02556996** · PHASE3 · COMPLETED · sponsor: **U.S. Army Medical Research and Development Command** · enrollment: 356 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **BIOLOGICAL:** ETEC/rCTB vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02556996
- **Lead sponsor:** U.S. Army Medical Research and Development Command
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-10
- **Primary completion:** 2001-03
- **Final completion:** 2002-04
- **Target enrollment:** 356 (ACTUAL)
- **Last updated:** 2015-10-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02556996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02556996, "Efficacy of an Oral, Killed Enterotoxigenic Escherichia Coli Vaccine in Prevention of Diarrhea in Egyptian Infants and Young Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02556996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*